Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S276000, C544S277000, C549S425000, C549S427000, C549S428000, C549S502000, C549S504000
Reexamination Certificate
active
07977344
ABSTRACT:
The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.
REFERENCES:
patent: 5962479 (1999-10-01), Chen
patent: 6376501 (2002-04-01), Isobe et al.
patent: 6552192 (2003-04-01), Hanuset et al.
patent: 7125880 (2006-10-01), Chen
patent: 7642350 (2010-01-01), Pryde
patent: 2001/0020030 (2001-09-01), Stewart et al.
patent: 2003/0187261 (2003-10-01), Havlicek et al.
patent: 2003/0236216 (2003-12-01), Devos et al.
patent: 2005/0054590 (2005-03-01), Averett
patent: 2006/0029642 (2006-02-01), Miljkovic et al.
patent: 2006/0148805 (2006-07-01), Chen et al.
patent: 2006/0264448 (2006-11-01), Pryde
patent: 2007/0190071 (2007-08-01), Kurimoto et al.
patent: 2007/0197478 (2007-08-01), Jones et al.
patent: 2008/0008682 (2008-01-01), Chong et al.
patent: 2008/0269240 (2008-10-01), Hashimoto et al.
patent: 2008/0300244 (2008-12-01), Bonnert et al.
patent: 2009/0047249 (2009-02-01), Graupe et al.
patent: 2009/0082332 (2009-03-01), Abbot et al.
patent: 2009/0099216 (2009-04-01), Millichip et al.
patent: 2009/0105212 (2009-04-01), Isobe et al.
patent: 2009/0118263 (2009-05-01), Hashimoto et al.
patent: 2009/0131458 (2009-05-01), Lazarides et al.
patent: 2009/0143400 (2009-06-01), McInally et al.
patent: 2009/0192153 (2009-07-01), Hashimoto et al.
patent: 2009/0202484 (2009-08-01), Chong et al.
patent: 2009/0324551 (2009-12-01), Carson et al.
patent: 2009/0325877 (2009-12-01), Grunt et al.
patent: 2010/0075995 (2010-03-01), Biggadike et al.
patent: 2010/0087443 (2010-04-01), Bonnert et al.
patent: 2010/0093998 (2010-04-01), Isobe et al.
patent: 2010/0099870 (2010-04-01), Isobe et al.
patent: 2010/0120799 (2010-05-01), Lazarides et al.
patent: 2010/0130491 (2010-05-01), Bonnert et al.
patent: 2010/0240623 (2010-09-01), Cook et al.
patent: 1939198 (2008-07-01), None
patent: 2004029054 (2004-04-01), None
patent: 2007028129 (2007-03-01), None
patent: 2007041863 (2007-04-01), None
patent: WO 2008004948 (2008-01-01), None
patent: 2008114008 (2008-09-01), None
patent: WO 2010018130 (2010-02-01), None
patent: WO 2010018131 (2010-02-01), None
patent: WO 2010018132 (2010-02-01), None
patent: WO 2010018134 (2010-02-01), None
Kurimoto et al.; “Prodrugs of 9-Benzyl-8-Hydroxy-2-(2-Hydroxyethylthio)Adenine: Potent Interferon Inducing Agents in Monkeys”; Chem. Pharm. Bull.; 2004; vol. 52, No. 4; pp. 466-469.
Hirota et al; “Discovery of 8-Hydroxyadenines as a Novel Type of Interferon Inducer”; J. Med. Chem.; 2002; vol. 45; pp. 5419-5422.
Isobe et al.; “Synthesis and Biological Evaluation of Novel 9-Substituted-8-Hydroxyadenine Derivatives as Potent Interferon Inducers”; J. Med. Chem.; 2006; vol. 49; pp. 2088-2095.
Lazarides Linos
Smith Stephen Allan
Stocker Richard
Theobald Colin Jack
Berch Mark L
Coulter Kathryn L.
GlaxoSmithKline LLC
LandOfFree
Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2679537